千亿·国际(中国)唯一官方网站
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
2020.07.07
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
2020.07.03
关于境外上市外资股(H股)公开发行价格的公告
2020.07.02
Price Determination
2020.06.30
2016年公司债券受托管理事务报告(2019年度)
2020.06.30
2019年公司债券2019年定期受托管理事务报告
2020.06.24
关于刊发H股招股说明书、H股发行价格区间及H股香港公开发售等事宜的公告
第一页
上一页
57
58
59
60
61
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.